Moreover, knockout or pharmacological inhibition of STAT6 specifically sensitized ALL cells to the central anti-leukemia drug cytarabine (Ara-C) and increased the incidence of Ara-C-induced apoptosis without altering the normal growth of ALL cells. This evidence concerns the gene STAT6 and acute lymphoblastic leukemia.